Association between cardiometabolic comorbidity and mortality in patients with atrial fibrillation
Abstract Background Patients with atrial fibrillation (AF) often suffer from cardiometabolic comorbidities, but the impact of the type and number of cardiometabolic comorbidities on the prognosis of AF patients remain unclear. Methods From August 2011 to December 2018, 23,838 AF patients from the Ch...
Saved in:
| Main Authors: | Zhaojie Dong, Chao Jiang, Liu He, Mingyang Gao, Ribo Tang, Nian Liu, Ning Zhou, Caihua Sang, Deyong Long, Xin Du, Jianzeng Dong, Changsheng Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cardiovascular Disorders |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12872-025-04784-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pro‐adrenomedullin as an independent predictive biomarker for heart failure in atrial fibrillation and flutter
by: Gaifeng Hu, et al.
Published: (2025-06-01) -
Sex-specific trends in the global burden and risk factors of atrial fibrillation and flutter from 1990 to 2021
by: Xiaodong Peng, et al.
Published: (2025-03-01) -
Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry study
by: Lara El Khalili, et al.
Published: (2025-03-01) -
Multimorbidity increases risk of cardiovascular outcomes in permanent atrial fibrillation: Data from the RACE II study
by: Colinda van Deutekom, et al.
Published: (2025-08-01) -
An Integrated Approach to the Management of a Multimorbid Patient with Atrial Fibrillation from the Standpoint of Modern Guidelines: Rivaroxaban is in Focus
by: V. N. Larina, et al.
Published: (2021-07-01)